Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26F4YYN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,465
Award facts
- Contract value 100% obligated
- $17,465.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,465.47 delivery order to AmerisourceBergen Drug Corp for 30-count bottles of XELJANZ XR 11 mg tablets, with performance at the contractor's facility in Conshohocken, Pennsylvania. This non-competed, firm fixed-price delivery order was executed on November 18, 2025, with an ultimate completion date of November 19, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026, which serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains a significant presence in federal medical procurement through its IDC with DLA. The company supplies a broad portfolio of pharmaceutical products and medical commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. XELJANZ XR is a brand-name immunosuppressant medication used primarily for rheumatoid arthritis treatment, consistent with AmerisourceBergen's extensive history of delivering specialty pharmaceuticals across multiple therapeutic domains through the DLA supply chain.
Quick answers
Who was awarded contract SPE2DR26F4YYN?
SPE2DR26F4YYN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26F4YYN worth?
The government has obligated $17,465 on SPE2DR26F4YYN.
Is contract SPE2DR26F4YYN an order under another contract?
Yes. SPE2DR26F4YYN is a delivery order under SPE2DR25D2010, an indefinite delivery contract.
Was contract SPE2DR26F4YYN competed?
The extent of competition for SPE2DR26F4YYN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award